FMP

FMP

Enter

MBX.TO - Microbix Biosystems ...

Financial Summary of Microbix Biosystems Inc.(MBX.TO), Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological

photo-url-https://financialmodelingprep.com/image-stock/MBX.TO.png

Microbix Biosystems Inc.

MBX.TO

TSX

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

0.325 CAD

0.005 (1.54%)

About

ceo

Mr. Cameron L. Groome

sector

Healthcare

industry

Biotechnology

website

https://microbix.com

exchange

TSX

Description

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and ...

CIK

N/A

ISIN

CA59501P1045

CUSIP

59501P104

Address

265 Watline Avenue

Phone

905 361 8910

Country

CA

Employee

100

IPO Date

Aug 13, 1996

Summary

CIK

-

Exchange

TSX

Industry

Biotechnology

Sector

Healthcare

CUSIP

59501P104

ISIN

CA59501P1045

Country

CA

Price

0.33

Beta

0.24

Volume Avg.

63.79k

Market Cap

44.66M

Shares

-

52-Week

0.23-0.45

DCF

-0.09

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

10.83

P/B

-

Website

https://microbix.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest MBX.TO News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep